Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Hum. Neurosci.

Sec. Brain Imaging and Stimulation

Volume 19 - 2025 | doi: 10.3389/fnhum.2025.1682852

This article is part of the Research TopicAI-driven diagnostic enhancements for neurological diseases using multimodal biosignalsView all 3 articles

Precision TMS through the Integration of Neuroimaging and Machine Learning: Optimizing Stimulation Targets for Personalized Treatment

Provisionally accepted
Bing  LiuBing Liu1Chunyun  HuChunyun Hu2Panxiao  BaoPanxiao Bao1*
  • 1Zhejiang Joint Research Institute of Applied Psychology, Hangzhou, China
  • 2Cixi Seventh people's hospital, Ningbo, China

The final, formatted version of the article will be published soon.

Transcranial Magnetic Stimulation (TMS), a noninvasive neuromodulation technique based on electromagnetic induction, modulates cortical excitability by inducing currents with a magnetic field. TMS has demonstrated significant clinical potential in the treatment of various neuropsychiatric disorders, including depression, anxiety, and Parkinson's disease. However, conventional TMS targeting methods that rely on anatomical landmarks do not adequately account for individual differences in brain structure and functional networks, leading to considerable variability in treatment responses. In recent years, advances in neuroimaging techniques—such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI)—together with the application of machine learning (ML) and artificial intelligence (AI) algorithms in big data analysis, have provided novel approaches for precise TMS targeting and individualized treatment. This review summarizes the latest developments in the integration of multimodal neuroimaging and AI technologies for precision neuromodulation with TMS. It focuses on critical issues such as imaging resolution, AI model generalizability, real-time feedback modulation, as well as data privacy and ethical considerations. Future prospects including closed-loop TMS control systems, cross-modal data fusion, and AI-assisted brain-computer interfaces (BCIs) are also discussed. Overall, AI-driven personalized TMS strategies hold promise for markedly enhancing treatment precision and clinical efficacy, thereby offering new theoretical and practical guidance for individualized treatment in neuropsychiatric and neurodegenerative disorders.

Keywords: Transcranial Magnetic Stimulation, Neuroimaging, artificial intelligence, Precision treatment, personalized medicine

Received: 09 Aug 2025; Accepted: 15 Sep 2025.

Copyright: © 2025 Liu, Hu and Bao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Panxiao Bao, zhexinli88@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.